Recent advances and new strategies in Leishmaniasis diagnosis

RCF De Brito, RDO Aguiar-Soares… - Applied Microbiology …, 2020 - Springer
Leishmaniasis is a set of complex and multifaceted syndromes, with different clinical
manifestations, caused by different species of the genus Leishmania spp. that can be …

Identification of asymptomatic Leishmania infections: a sco** review

AV Ibarra-Meneses, A Corbeil, V Wagner… - Parasites & vectors, 2022 - Springer
Abstract Background Asymptomatic Leishmania infection may play an important role in the
transmission of the parasite in endemic areas. At present there is no consensus on the …

Bisphosphonate-based molecules as potential new antiparasitic drugs

JC Branco Santos, JA De Melo, S Maheshwari… - Molecules, 2020 - mdpi.com
Neglected tropical diseases such as Chagas disease and leishmaniasis affect millions of
people around the world. Both diseases affect various parts of the globe and drugs …

Parasite genotype is a major predictor of mortality from visceral leishmaniasis

CA Grace, KS Sousa Carvalho, MI Sousa Lima… - MBio, 2022 - Am Soc Microbiol
Visceral leishmaniasis (VL) is a potentially fatal disease caused mainly by Leishmania
infantum in South America and Leishmania donovani in Asia and Africa. Disease outcomes …

Potential biomarkers for asymptomatic visceral leishmaniasis among Iraq-deployed US Military personnel

FF de Araujo, I Lakhal-Naouar, N Koles, S Raiciulescu… - Pathogens, 2023 - mdpi.com
Visceral leishmaniasis (VL) is a chronic infection caused by Leishmania (L.) donovani or L.
infantum parasites. Despite having the infection, most individuals never develop the clinical …

Parasite Detection in Visceral Leishmaniasis Samples by Dye-Based qPCR Using New Gene Targets of Leishmania infantum and Crithidia

NT Takamiya, LA Rogerio, C Torres… - Tropical Medicine and …, 2023 - mdpi.com
Visceral leishmaniasis (VL) is a neglected disease considered a serious public health
problem, especially in endemic countries. Several studies have discovered monoxenous …

Improved Performance of ELISA and Immunochromatographic Tests Using a New Chimeric A2‐Based Protein for Human Visceral Leishmaniasis Diagnosis

MM Figueiredo, ARR Dos Santos… - Journal of …, 2021 - Wiley Online Library
Human visceral leishmaniasis (VL) is a major public health problem worldwide, leading to
significant mortality rates if not properly treated and controlled. Precise identification of …

Total serum N-glycans mark visceral leishmaniasis in human infections with Leishmania infantum

GN Porcino, MR Bladergroen, V Dotz, S Nicolardi… - Iscience, 2023 - cell.com
Visceral leishmaniasis (VL) is a clinical form of leishmaniasis with high mortality rates when
not treated. Diagnosis suffers from invasive techniques and sub-optimal sensitivities. The …

[HTML][HTML] Evaluation of chemokines MIG and IP-10 as immunological biomarkers of human visceral leishmaniasis: A systematic review

BEF Monteiro, ED da Silva, WL Barbosa Júnior… - Tropical Medicine and …, 2024 - mdpi.com
Visceral leishmaniasis (VL) is a neglected tropical disease that is potentially fatal when
untreated. Current diagnostic methods have limitations that contribute to ongoing …

An assessment of serological techniques for the identification of asymptomatic visceral leishmaniasis in blood donors in northeastern Brazil

LP Silva, ED Silva, AM de Souza Pereira… - Research, Society and …, 2022 - rsdjournal.org
Background: Visceral leishmaniasis (VL) is a neglected disease caused by species of the
Leishmania donovani complex and transmitted mainly by the bite of infected sandflies. A …